Laboratorios Richmond S.A.C.I.F. (BASE: RICH)
Health Care · Pharmaceuticals · AR
AR$1,520.00
+2.36% today · +36.3% 1Y
Laboratorios Richmond S.A.C.I.F. (BASE: RICH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $80.66M and employs 620 people.
Over the last twelve months the share price has gained 36.3%, trading between 1.03K and 2.30K.
Tweenvest scores Laboratorios Richmond S.A.C.I.F. across four factors: quality 49/100, value 63/100, growth 54/100, dividend 38/100. Its strongest factor is value.
RICH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $80.66M
- Revenue (TTM)
- $76.96M
- P/E
- 9.41
- EPS
- 154.85
- Dividend yield
- 1.77%
- Beta (5Y)
- -0.63
- 52-week high
- AR$2,300.00
- 52-week low
- AR$1,030.00
- Avg volume (3M)
- —
- Shares outstanding
- 80.75M
- Employees
- 620
- Next earnings
- —
About Laboratorios Richmond S.A.C.I.F.
Laboratorios Richmond S.A.C.I.F. is a pharmaceutical firm focused on the development and production of a diverse range of medicinal products. Their extensive portfolio includes antiretroviral treatments for human immunodeficiency virus (HIV), as well as therapies for oncology and oncohematology conditions. The company also supplies various cardiometabolic medications, such as those for blood pressure reduction, cholesterol management, platelet aggregation inhibition, and blood sugar control. Additionally, they produce neurological and psychiatric drugs, covering analgesics, antipsychotics, antidepressants, anti-dementia agents, antiepileptics, hypnotics, and treatments for multiple sclerosis. These pharmaceutical offerings are distributed across Latin America, Africa, Asia, and the Middle East. Founded in 1935, Laboratorios Richmond S.A.C.I.F. is headquartered in Buenos Aires, Argentina.
- ISIN
- ARLRIC300027
- Founded
- 1959
- Listed since
- Jul 18, 2025
- Exchange
- Buenos Aires Stock Exchange
- Currency
- ARS
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Merdury Biopharmaceutical CorporationTPEX: 6932 | $82.03M | NT$6.11 | +1.50% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd.TWSE: 1762 | $81.49M | NT$33.75 | +0.15% |
| Telomir Pharmaceuticals, Inc.NasdaqCM: TELO | $81.15M | $1.12 | -5.08% |
| Euroapi S.A.ENXTPA: EAPI | $80.83M | €0.75 | -0.79% |
| High Tech Pharm Co., Ltd.KOSDAQ: A106190 | $80.22M | ₩10,160.00 | +2.83% |
| Rafael Holdings, Inc.NYSE: RFL | $80.08M | $1.48 | -3.90% |
| The IBN SINA Pharmaceutical Industry PLCDSE: IBNSINA | $79.97M | Tk315.00 | -1.01% |
| Euro-Med Laboratories Phil., Inc.PSE: EURO | $79.57M | ₱1.21 | +0.83% |
Figures last refreshed Oct 4, 2026.